✦ LIBER ✦

685 A phase 3, randomized, double-blind, placebo-controlled study of darbepoetin alfa in patients (pts) with lymphoproliferative malignancies

✍ Scribed by M. Hedenus; J. San Miguel; D. Watson; J. Matchum; G. Rossi; T.J. Littlewood

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

950 Darbepoetin alfa significantly impro

✍ H. Michael; J. Kallich; J. San Miguel; D. Watson; J. Matcham; T.J. Littlewood 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Effect of Darbepoetin Alfa on Exercise T

✍ Piotr Ponikowski; Stefan D. Anker; Joanna Szachniewicz; Darlington Okonko; Mark 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 533 KB

1104 POSTER Patient-level integrated ana

✍ H. Ludwig; J. Crawford; A. Österborg; A. Fleishman; T. Lillie; T. Süto; J. Glasp 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Darbepoetin alfa administered every 3 we

✍ D. Kotasek; G. Steger; W. Faught; C. Underhill; E. Poulsen; A.B. Colowick; G. Ro 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 280 KB

Erythropoietin Treatment under Polychemo

✍ Ch. Kurz; Ch. Marth; G. Windbichler; M. Lahousen; M. Medl; N. Vavra; P. Sevelda 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Vandetanib in patients with inoperable h

✍ Chiun Hsu; Tsai-Sheng Yang; Teh-Ia Huo; Ruey-Kuen Hsieh; Chih-Wei Yu; Wei-Shou H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 881 KB